FDA.reportPublic FDA data

LOPINAVIR

Substance profile for UNII 2494G1JF75, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for LOPINAVIR
Structure render from PubChem CID 92727

Substance Identity#

UNII
2494G1JF75
Preferred term
LOPINAVIR
Registry number
192725-17-0
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C37H48N4O5
Chemical structure for LOPINAVIR
Structure render from PubChem CID 92727

Chemical And Database Identifiers#

InChIKey
KJHKTHWMRKYKJE-SUGCFTRWSA-N
SMILES
CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4
RxCUI
195088
PubChem
92727
NCIt
C2095
INN ID
7798

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound92727https://pubchem.ncbi.nlm.nih.gov/compound/92727
PubChem InChIKey SearchKJHKTHWMRKYKJE-SUGCFTRWSA-Nhttps://pubchem.ncbi.nlm.nih.gov/#query=KJHKTHWMRKYKJE-SUGCFTRWSA-N
RxNorm195088https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=195088
NCI ThesaurusC2095https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2095
FDA Substance Registration System2494G1JF75https://precision.fda.gov/uniisearch/srs/unii/2494G1JF75

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
LOPINAVIRACTIVE INGREDIENT2494G1JF75These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir/ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir/ritonavir) Solution for Oral use Initial U.S. Approval: 20001
LOPINAVIRACTIVE MOIETY2494G1JF75These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir/ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir/ritonavir) Solution for Oral use Initial U.S. Approval: 20001
LOPINAVIRACTIVE MOIETY2494G1JF75These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir/ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir/ritonavir) Solution for Oral use Initial U.S. Approval: 20001
LOPINAVIRACTIVE INGREDIENT2494G1JF75These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir/ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir/ritonavir) Solution for Oral use Initial U.S. Approval: 20001
LOPINAVIRACTIVE MOIETY2494G1JF75These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 20002
LOPINAVIRACTIVE INGREDIENT2494G1JF75These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 20002
LopinavirACTIVE MOIETY2494G1JF75These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 20001
LopinavirACTIVE INGREDIENT2494G1JF75These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 20001
LOPINAVIRACTIVE MOIETY2494G1JF75These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 20001
LOPINAVIRACTIVE INGREDIENT2494G1JF75These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 20001
LOPINAVIRACTIVE INGREDIENT2494G1JF75KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED KALETRA (LOPINAVIR AND RITONAVIR) SOLUTION [ABBVIE INC.]1567
LOPINAVIRACTIVE MOIETY2494G1JF75KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED KALETRA (LOPINAVIR AND RITONAVIR) SOLUTION [ABBVIE INC.]1567
LOPINAVIRACTIVE INGREDIENT2494G1JF75KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]1405
LOPINAVIRACTIVE MOIETY2494G1JF75KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]1405
LOPINAVIRACTIVE INGREDIENT2494G1JF75KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [CARDINAL HEALTH]4
LOPINAVIRACTIVE MOIETY2494G1JF75KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [CARDINAL HEALTH]4
LOPINAVIRACTIVE INGREDIENT2494G1JF75KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
LOPINAVIRACTIVE MOIETY2494G1JF75KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1